e8vk
United States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
June 8, 2010
(Date of Report)
ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-20852
|
|
16-1387013 |
(State of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.) |
|
|
|
2000 Technology Parkway, Newark, New York
|
|
14513 |
(Address of principal executive offices)
|
|
(Zip Code) |
(315) 332-7100
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 8, 2010, Ultralife Corporation (the Company) held its 2010 annual meeting of shareholders
(the Annual Meeting). At the Annual Meeting, the Companys shareholders voted on each of the
matters described below.
1. The Companys shareholders elected eight directors, which constitute the Companys entire board
of directors, to serve for a term of one year and until their successors are duly elected and
qualified. The number of shares that (i) voted for the election of each director and (ii) withheld
authority to vote for each director is summarized in the table below.
|
|
|
|
|
|
|
|
|
Director Nominee |
|
Votes For |
|
Votes Withheld |
Steven M. Anderson |
|
|
8,092,628 |
|
|
|
352,035 |
|
Patricia C. Barron |
|
|
8,012,234 |
|
|
|
432,429 |
|
James A. Croce |
|
|
8,103,795 |
|
|
|
340,868 |
|
John D. Kavazanjian |
|
|
8,096,045 |
|
|
|
348,628 |
|
Thomas L. Saeli |
|
|
8,089,845 |
|
|
|
354,818 |
|
Robert W. Shaw II |
|
|
8,095,295 |
|
|
|
349,368 |
|
Ranjit C. Singh |
|
|
8,092,780 |
|
|
|
351,883 |
|
Bradford T. Whitmore |
|
|
7,954,034 |
|
|
|
490,629 |
|
2. The Companys shareholders ratified the selection of BDO Seidman, LLP as the Companys
independent registered public accounting firm for the fiscal year ending December 31, 2010. The
number of shares that voted for, against and abstained from voting for the ratification of the
selection of BDO Seidman, LLP is summarized in the table below.
|
|
|
|
|
|
|
|
|
Votes For |
|
Votes Against |
|
Abstentions |
13,833,011 |
|
|
744,092 |
|
|
|
28,927 |
|
Item 8.01 Other Events.
Following the Annual Meeting, the newly-elected board of directors met and took the actions
described below.
Committee Assignments
The board of directors changed the composition of each committee of the board of directors as
follows:
Audit and Finance Committee:
Thomas L. Saeli Chair
Patricia C. Barron
Robert W. Shaw II
Compensation and Management Committee:
Ranjit C. Singh Chair
Steven M. Anderson
James A. Croce
Governance Committee:
Patricia C. Barron Chair
Steven M. Anderson
James A. Croce
Strategy and Corporate Development Committee
Robert W. Shaw II Chair
Thomas L. Saeli
Ranjit C. Singh
The Companys board chair, Bradford T. Whitmore, will serve as an ex-officio member of each board
committee. As an ex-officio member of each board committee, Mr. Whitmore will be able to attend
and participate in all committee meetings but he will not be able to vote as a committee member and
he will not receive any compensation for his committee service.
Board Compensation
The board of directors modified the Companys cash compensation for directors by terminating the
payment of cash meeting fees to each director for each board and committee meeting attended. Each
director will instead receive a larger board and committee cash retainer. Each non-employee
director will receive an annual cash retainer of $20,000, except for the board chair, who will
receive an annual cash retainer of $28,000. In addition, each director who is a member of a board
committee will receive an additional cash retainer for such committee service as summarized in the
table below.
|
|
|
|
|
|
|
|
|
|
|
Annual Retainer for |
|
|
Annual Retainer for |
|
|
|
Committee Members |
|
|
Committee Chair |
|
Audit and Finance Committee |
|
$ |
6,750 |
|
|
$ |
16,750 |
|
Compensation and Management Committee |
|
$ |
5,250 |
|
|
$ |
13,250 |
|
Governance Committee |
|
$ |
4,500 |
|
|
$ |
9,500 |
|
Strategy and Corporate Development Committee |
|
$ |
3,750 |
|
|
$ |
8,750 |
|
The board of directors did not modify the Companys equity award for directors, which
continues to be grants of the Companys common stock with an aggregate annual value of $40,000 for
each non-employee director and $66,000 for the board chair.
Officer Positions
In accordance with the Companys By-laws, the board elected the following corporate officers:
|
|
|
Board Chair:
|
|
Bradford T. Whitmore |
President and Chief Executive Officer:
|
|
John D. Kavazanjian |
Secretary:
|
|
Peter F. Comerford |
Treasurer:
|
|
Philip A. Fain |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
Date: June 10, 2010 |
ULTRALIFE CORPORATION
|
|
|
By: |
/s/ Peter F. Comerford
|
|
|
|
Peter F. Comerford |
|
|
|
Vice President of Administration and
General Counsel |
|
|